Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834973
Status:
TERMINATED
Last Update Posted:
2023-04-18
First Post:
2021-03-29
Brief Title:
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
Sponsor:
Organization:
QBiotics Group Limited